id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-2330-0035,FDA,FDA-2019-D-2330,Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers Guidance for Industry,Other,Guidance,2021-12-27T05:00:00Z,2021,12,2021-12-27T05:00:00Z,,2024-11-12T23:35:32Z,,1,0,0900006484efda35
FDA-2019-D-2330-0034,FDA,FDA-2019-D-2330,Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2021-12-27T05:00:00Z,2021,12,2021-12-27T05:00:00Z,,2021-12-27T14:29:13Z,2021-28051,0,0,0900006484efd807